Nachrichten June 15, 2022

Oaktree Acquisition Corp. II’s Business Combination with Alvotech

Shearman & Sterling represented Morgan Stanley, Deutsche Bank Securities, Credit Suisse Securities (USA), and Citigroup Global Markets collectively acting as placement agents in connection with approximately $175 million equity PIPE issued in connection with the business combination of Oaktree Acquisition Corp. II and Alvotech, which was announced on December 7, 2021 and consummated on June 15, 2022.

Alvotech is a leading global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Oaktree Acquisition Corp. II is a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management.

The Shearman & Sterling team below included associate Corinne McCrum (New York-Capital Markets).

The Team